Nurix therapeutics CSO Hansen sells $52k in shares
NeutralFinancial Markets

Nurix Therapeutics' Chief Scientific Officer, Hansen, has sold $52,000 worth of shares in the company. This transaction is noteworthy as it reflects the ongoing financial activities of key executives within the biotech sector, which can influence investor sentiment and market dynamics.
— Curated by the World Pulse Now AI Editorial System











